Abstract

In excess of % of human cancer incidents have a viral cofactor. Epidemiological studies of idiopathic human cancers indicate that additional tumor viruses remain to be discovered. Recent advances in sequencing technology have enabled systematic screenings of human tumor transcriptomes for viral transcripts. However, technical problems such as low abundances of viral transcripts in large volumes of sequencing data, viral sequence divergence, and homology between viral and human factors significantly confound identification of tumor viruses. We have developed a novel computational approach for detecting viral transcripts in human cancers that takes the aforementioned confounding factors into account and is applicable to a wide variety of viruses and tumors. We apply the approach to conducting the first systematic search for viruses in neuroblastoma, the most common cancer in infancy. The diverse clinical progression of this disease as well as related epidemiological and virological findings are highly suggestive of a pathogenic cofactor. However, a viral etiology of neuroblastoma is currently contested. We mapped transcriptomes of neuroblastoma as well as positive and negative controls to the human and all known viral genomes in order to detect both known and unknown viruses. Analysis of controls, comparisons with related methods, and statistical estimates demonstrate the high sensitivity of our approach. Detailed investigation of putative viral transcripts within neuroblastoma samples did not provide evidence for the existence of any known human viruses. Likewise, de-novo assembly and analysis of chimeric transcripts did not result in expression signatures associated with novel human pathogens. While confounding factors such as sample dilution or viral clearance in progressed tumors may mask viral cofactors in the data, in principle, this is rendered less likely by the high sensitivity of our approach and the number of biological replicates analyzed. Therefore, our results suggest that frequent viral cofactors of metastatic neuroblastoma are unlikely.

Highlights

  • To date, pathogenic agents are known to be causally related to 20% of human cancer cases [1] and significantly affect the global health burden of this disease [2]

  • Many human cancers are caused by infections with tumor viruses and identification of these pathogens is considered a critical contribution to cancer prevention

  • We have developed Virana, a novel computational approach for identifying tumor viruses in human cancers that is applicable to a wide variety of tumors and viruses

Read more

Summary

Introduction

Pathogenic agents are known to be causally related to 20% of human cancer cases [1] and significantly affect the global health burden of this disease [2]. The majority of these agents comprise oncogenic viruses such as human papilloma virus (HPV), Epstein-Barr virus (EBV), hepatitis B virus (HBV), and hepatitis C virus (HCV) [3]. Stage 4S is characterized by an age of presentation between in utero and 18 months, metastases confined to liver, skin, lymph nodes and bone marrow, and its ability to regress spontaneously [14,15]. While genes related to neuronal differentiation have been described to be upregulated in stage 4S in comparison to stage 4 neuroblastoma, thereby indicating distinct levels of neuronal differentiation [17], little is currently known about the differences between molecular etiologies of stage 4 and stage 4S neuroblastoma

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.